{
    "status": "ok",
    "totalResults": 1,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Voyager Therapeutics, Inc.",
            "title": "Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference",
            "description": "CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that Chief Executive Officer Alfred W. Sandrock, Jr.,\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748498/36461/en/Voyager-Therapeutics-to-Present-at-the-Chardan-Genetic-Medicines-Conference.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/3fe5c08d-e9d5-4ef6-944b-503007d056b0",
            "publishedAt": "2023-09-25T11:00:00Z",
            "content": "CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today ann\u2026 [+1799 chars]"
        }
    ]
}